NCT03865732View on ClinicalTrials.gov

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 17, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

June 20, 2022

Conditions
PCDH19-Related Epilepsy
Interventions
DRUG

Ganaxolone

active drug

DRUG

Placebo

inactive

Trial Locations (12)

1083

Marinus Research Site, Budapest

5591

Marinus Research Site, Heeze

8025

Marinus Research Site, Zwolle

17403

Marinus Research Site, York

27710

Marinus Research Site, Durham

50139

Marinus Research Site, Florence

72202

Marinus Research Site, Little Rock

84113

Marinus Research Site, Salt Lake City

90095

Marinus Research Site, Los Angeles

94158

Marinus Research Site, San Francisco

00165

Marinus Research Site, Rome

30-363

Marinus Research Site, Krakow

Sponsors
All Listed Sponsors
lead

Marinus Pharmaceuticals

INDUSTRY

NCT03865732 - Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study) | Biotech Hunter | Biotech Hunter